stockrowViemed Healthcare, Inc.
VMD Healthcare Medical Devices
Viemed Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $270.3 million, up 20.5% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +33.3%
- Free cash flow
- −67.6%
- Total debt
- −76.2%
Quarter to September 2026, against a year earlier
Follow VMD
Alert me
Viemed Healthcare, Inc. (VMD) EV/Sales
As of 5 November 2026, Viemed Healthcare, Inc. (VMD) trades at a EV/Sales of 1.1×. Over the past ten years it has ranged from 0.0× (December 2018) to 5.2× (June 2020); the current reading is higher than 17% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | (19.65%) |
| FY2024 | 1.3× | (19.35%) |
| FY2023 | 1.6× | (17.21%) |
| FY2022 | 2.0× | 26.45% |
| FY2021 | 1.6× | (25.86%) |
| FY2020 | 2.1× | (27.03%) |
| FY2019 | 2.9× | 40.66% |
| FY2018 | 2.1× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.1× | (23.12%) |
| Jun 2026 | 1.4× | 16.27% |
| Mar 2026 | 1.2× | 15.77% |
| Dec 2025 | 1.1× | (0.36%) |
| 31 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OFIX ORTHOFIX MEDICAL INC. compare | 0.6× |
| VMD Viemed Healthcare, Inc. | 1.1× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 2.4× |
| MOBI Mobia Medical, Inc compare | 4.6× |
| SI Shoulder Innovations, Inc. compare | 5.4× |
| CLPT ClearPoint Neuro, Inc. compare | 6.0× |
| RCEL Avita Medical Inc. compare | 6.7× |
| SSII SS Innovations International, Inc. compare | 7.1× |
| CV CapsoVision, Inc. compare | 21.5× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)